RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Jumpinjack, In his recent presentation, Dr. Manuso had the Dronabinol Phase 2 results coming in Q3-2016 (July, Aug, Sept), and the trial doses for 6 weeks, so the enrollment would presumably have to be completed by approx mid-May to mid-Aug. So that's probably the general timeframe to expect, and the company will likely announce the completion of enrollment in a press release, or perhaps Dr. Manuso will provide an estimate in the upcoming March 15 presentation.

I'm figuring they'll announce some type of additional funding fairly soon since the last press release said the CX-1739 RD trial will start in late March. By my calculations I think they're still light on the funding side, though they may have enough to get the trial started, but will likely need more funds before long. However the Dronabinol trial is already fully funded by the NIH.

Getting data from 2 trials during 2016 will be very interesting, and should generate some anticipation/buzz for the company.